ダウンロード数: 178
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
bmjopen-2014-007049.pdf | 672.37 kB | Adobe PDF | 見る/開く |
タイトル: | Prognostic utility of serum CRP levels in combination with CURB-65 in patients with clinically suspected sepsis: a decision curve analysis |
著者: | Yamamoto, S. Yamazaki, S. Shimizu, T. Takeshima, T. Fukuma, S. Yamamoto, Y. Tochitani, K. Tsuchido, Y. Shinohara, K. Fukuhara, S. |
著者名の別形: | 福原, 俊一 山本, 洋介 |
発行日: | 28-Apr-2015 |
出版者: | BMJ Publishing Group |
誌名: | BMJ Open |
巻: | 5 |
号: | 4 |
論文番号: | e007049 |
抄録: | [Objectives] The prognostic utility of serum C reactive protein (CRP) alone in sepsis is controversial. We used decision curve analysis (DCA) to evaluate the clinical usefulness of combining serum CRP levels with the CUBR-65 score in patients with suspected sepsis. [Design] Retrospective cohort study. [Setting] Emergency department (ED) of an urban teaching hospital in Japan. [Participants] Consecutive ED patients over 15 years of age who were admitted to the hospital after having a blood culture taken in the ED between 1 January 2010 and 31 December 2012. [Main outcome measures] 30-day in-hospital mortality. [Results] Data from 1262 patients were analysed for score evaluation. The 30-day in-hospital mortality was 8.4%. Multivariable analysis showed that serum CRP ≥150 mg/L was an independent predictor of death (adjusted OR 2.0; 95% CI 1.3 to 3.1). We compared the predictive performance of CURB-65 with the performance of a modified CURB-65 with that included CRP (≥150 mg/L) to quantify the clinical usefulness of combining serum CRP with CURB-65. The areas under the receiver operating characteristics curves of CURB-65 and a modified CURB-65 were 0.76 (95% CI 0.72 to 0.80) and 0.77 (95% CI 0.72 to 0.81), respectively. Both models had good calibration for mortality and were useful among threshold probabilities from 0% to 30%. However, while incorporating CRP into CURB-65 yielded a significant category-free net reclassification improvement of 0.387 (95% CI 0.193 to 0.582) and integrated discrimination improvement of 0.015 (95% CI 0.004 to 0.027), DCA showed that CURB-65 and the modified CURB-65 score had comparable net benefits for prediction of mortality. [Conclusions] Measurement of serum CRP added limited clinical usefulness to CURB-65 in predicting mortality in patients with clinically suspected sepsis, regardless of the source. |
著作権等: | This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
URI: | http://hdl.handle.net/2433/216068 |
DOI(出版社版): | 10.1136/bmjopen-2014-007049 |
PubMed ID: | 25922102 |
出現コレクション: | 学術雑誌掲載論文等 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。